Who Defines Autism Care? Single-Discipline Guidelines Risk Distorting Health Policy in the US

ABSTRACT

Clinical practice guidelines for children with autism are increasingly produced by single-discipline organizations whose structural interests may conflict with comprehensive patient welfare. When such guidelines are adopted as the basis for policy by regulatory bodies and payers, their methodological deficiencies become a concern for clinicians and payers. To examine methodological shortcomings in guidelines developed outside established standards, we used the recently released Autism Spectrum Disorders (ASD) Assessment Guidelines for Behavior Analysts, produced by the Council of Autism Service Providers and the Association of Professional Behavior Analysts, as a primary case study.

We evaluated these guidelines against 2 benchmarks: the 2011 Institute of Medicine framework, which requires systematic evidence review, multidisciplinary stakeholder involvement, and rigorous conflict-of-interest management; and the International Classification of Functioning, Disability and Health Core Sets for Autism Spectrum Disorder, which was developed through international consensus across 10 disciplines and 43 countries. Against these standards, the examined guidelines did not address 9 clinically significant domains, including sensory processing, trauma, physical health, motor development, and self-determination—areas with direct implications for the design of behavioral treatment.

We argue that discipline-dominated guideline development systematically narrows clinical frameworks in ways that may displace physician judgment and family preferences while inadequately serving children’s developmental complexity. We call for standards-compliant guideline development that is inclusive of pediatric, psychiatric, educational, family, and autistic community perspectives. Clinicians, payers, and regulators should critically evaluate methodological provenance before granting guidelines authority in clinical policy or coverage decisions.

Am J Manag Care. 2027;33(2):In Press

doi:10.37765/ajmc.2026.90051

Takeaway Points

Single-discipline autism guidelines increasingly drive coverage decisions, yet many fail Institute of Medicine (IOM) standards—exposing children, families, and clinicians to real risk.

• Trade association guidelines lacking multidisciplinary input or conflict-of-interest oversight can distort determinations of medical necessity when adopted by payers and regulators.
• Frameworks omitting sensory processing, trauma, executive function, and sleep produce incomplete clinical pictures, undermining treatment planning and service authorization.
• Managed-care decision makers should scrutinize guideline methodology before granting coverage authority—methodological gaps directly affect the care that children can access.
• IOM-compliant guidelines, with multidisciplinary stakeholder input, are essential to ensuring that coverage policy reflects the full developmental complexity of children with autism.

Clinical practice guidelines increasingly function as de facto pediatric policy instruments in the US, shaping what care is authorized, reimbursed, and delivered to children.¹ In autism care, however, some guidelines now used by payers and regulators are developed by single-discipline organizations without adherence to established standards for guideline development.² When such guidelines are operationalized in coverage and regulatory frameworks, their limitations do not remain theoretical—they can directly constrain the scope of care available to children.

Guidelines are among medicine’s most powerful tools. Rigorously developed, they translate complex evidence into recommendations that improve care and reduce unwarranted variation; poorly developed, they can entrench structural bias and narrow clinical practice. Over several decades, medicine has built safeguards to prevent these failures. Yet autism care presents a growing exception: Guidelines are increasingly produced outside these safeguards by organizations whose disciplinary scope—and, in some cases, financial interests—may not align with the full developmental needs of children.

Efforts to standardize guideline development emerged in response to wide variation in quality and its consequences for patient care.³ Early guidelines were criticized for limited transparency and inadequate conflict-of-interest management.⁴ These concerns led to the Institute of Medicine’s 2011 report Clinical Practice Guidelines We Can Trust,⁵ which established widely accepted standards, including systematic evidence review, multidisciplinary stakeholder involvement, explicit grading of recommendations, rigorous conflict-of-interest management, and independent external review. These reforms were grounded in evidence that sponsorship and conflicts can influence recommendations; a Cochrane review found that guideline authors with conflicts of interest were more likely to produce favorable recommendations.⁴

These safeguards are not discipline-specific. They apply to any entity producing clinical guidance—particularly when that guidance may influence service utilization. Trade associations and provider networks that benefit from the delivery of specific services occupy a structurally different position from multidisciplinary clinical bodies. Specialty societies derive credibility from scientific rigor and patient outcomes; trade organizations are designed to advance a defined sector. When such organizations develop guidelines that are later adopted in policy, questions of methodological rigor and scope become central to child health.

Autism Guidelines

Recent autism guideline efforts illustrate these risks. Initially released in March 2026, the Autism Spectrum Disorders (ASD) Assessment Guidelines for Behavior Analysts, developed by the Council of Autism Service Providers (CASP) and the Association of Professional Behavior Analysts,⁶ provide a useful case. The guidelines were developed without broad multidisciplinary participation, with 19 of the 24 listed contributors being board certified behavior analysts and no representation from pediatricians, child psychiatrists, speech-language pathologists, developmental scientists, or autistic individuals and families. Similarly, the Autism Spectrum Disorder Standard Set developed by the International Consortium for Health Outcomes Measurement—and cited in the CASP guidelines—was created by a working group in which a majority of members were behavior analysts, several of whom held leadership roles within sponsoring organizations, without declared conflicts of interest.⁷

These examples reflect a broader pattern: guideline panels dominated by members of the discipline whose services the guidelines govern, with limited external oversight and insufficient transparency on conflicts of interest. Although such efforts may be technically rigorous within a discipline, they risk narrowing the clinical frame when applied to complex, multisystem conditions such as autism.

Autism is a neurodevelopmental condition shaped by interacting biological, psychological, and social factors. Optimal care requires integrating evidence across disciplines and incorporating the perspectives of autistic individuals and their families.⁸ When guideline development is controlled by a single discipline, clinical questions, evidence selection, and outcome definitions are filtered through that discipline’s lens. This is not a question of competence; it is a question of scope. A framework optimized for a single domain of care cannot fully capture the child’s developmental complexity.

A useful benchmark for scope is provided by the International Classification of Functioning, Disability and Health Core Sets for Autism Spectrum Disorder.⁹ These were developed through a multistage international consensus process involving systematic literature review, expert input from 10 disciplines across 43 countries, qualitative research with individuals with autism and their families, and clinical validation studies. The resulting framework spans body functions, activities and participation, and environmental factors—domains that reflect how children live, learn, and develop over time.

When the CASP assessment guidelines are examined against this benchmark, multiple clinically significant domains are absent, including sensory processing, physical health, motor development, cognitive function, participation in childhood activities, social belonging, family system function, self-determination and identity, and trauma. These are not peripheral concerns. They shape how children engage with their environments, how behaviors are expressed and interpreted, and how treatment plans are designed.

In practice, such omissions matter because guidelines do not merely describe care—they help define its boundaries. When adopted by payers or regulators, they influence what is assessed, what is documented, and ultimately what services are authorized. An assessment framework that omits key domains produces an incomplete clinical picture; what is not assessed cannot inform treatment planning, referrals, or coverage decisions.

Consider trauma. Children with autism may experience elevated rates of adverse childhood experiences, and trauma-related responses are often misinterpreted as features of autism itself.¹⁰ Yet the CASP guidelines do not include a trauma assessment domain, validated screening tools, or interpretive guidance. Similar gaps exist for sleep, sensory processing, and medical comorbidities—factors that directly affect attention, behavior, and learning. These omissions do not eliminate the influence of these factors, but render them invisible within the treatment framework.

Administering or reviewing a validated sensory profile, a sleep-quality questionnaire, a motor assessment, or a trauma screening instrument does not require a behavior analyst to deliver occupational therapy, sleep medicine, or trauma-focused psychotherapy. It requires them to understand the child they are treating. Every domain identified has direct implications for behavioral treatment design. Sensory processing shapes accessible environments and influences participation across virtually every life domain. Executive function—memory, inhibitory control, cognitive flexibility—determines whether a child can wait, sequence instructions, or tolerate change. Sleep, gastrointestinal health, and trauma history modulate attention, regulate learning, and shape the meaning of behavioral presentations that could otherwise be misread as skill deficits. And without tools for measuring actual participation in childhood—friendship, belonging, identity, goals the child would choose for themselves—treatment risks optimizing for the treatment framework’s priorities rather than the child’s own. Behavior analysts who do not assess these domains do not escape their influence; they operate under them unknowingly.

Conclusion

The issue is not whether behavior analysis—or any single discipline—has an important role in autism care. It does. The issue is whether a guideline developed within a single discipline, absent multidisciplinary integration, can adequately define the scope of care for a heterogeneous population.¹¹ When such guidelines are elevated to policy, they risk displacing physician judgment, constraining family choice, and prioritizing what is measurable within a single framework over what is meaningful for the child’s development.

This dynamic reflects a broader governance problem in the US health system. In the absence of a unified standard for guideline adoption, authority is fragmented across professional organizations, payers, and state regulators. In this environment, guidelines produced by well-organized sectors can acquire outsized influence, regardless of whether they meet established methodological standards.¹² The result is not simply variation—it is the potential redefinition of care itself.

The safeguards developed over decades of guideline reform exist precisely to prevent this outcome. Standards such as those articulated by the Institute of Medicine are not procedural formalities; they are mechanisms to ensure that clinical recommendations reflect the full range of relevant evidence and perspectives, rather than the priorities of any single group.

Organizations developing autism-related guidelines should adhere to these standards, including transparent processes, systematic evidence review, rigorous conflict-of-interest management, and meaningful, multidisciplinary representation encompassing pediatric, psychiatric, educational, family, and autistic community perspectives. Equally important, clinicians, payers, and regulators should critically evaluate the methodological provenance of guidelines before incorporating them into policy or coverage decisions.¹³

In practice, guidelines do not simply inform care—they define its limits. Ensuring that those limits are set through rigorous, inclusive, and standards-based processes is essential to protecting the developmental potential of children with autism in the United States.

Author Affiliations: Perimeter Healthcare (SM), Alpharetta, GA; University of Missouri (KS), Columbia, MO.

Source of Funding: None

Author Disclosures: The authors report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.

Authorship Information: Concept and design (SM, KS); acquisition of data (SM); analysis and interpretation of data (SM); drafting of the manuscript (SM, KS); and critical revision of the manuscript for important intellectual content (SM, KS).

Address Correspondence to: Steven Merahn, MD, Perimeter Healthcare, 2520 Northwinds Pkwy, Suite 550, Alpharetta, GA 30009

REFERENCES

1. Giardino AP, Hudak ML, Sood BG, Pearlman SA; Committee on Child Health Financing. Considerations in the determination of medical necessity in children: application to contractual language. Pediatrics. 2022;150(3):e2022058882. doi:10.1542/peds.2022-058882
2. Council of Autism Service Providers. Applied Behavior Analysis Practice Guidelines for the Treatment of Autism Spectrum Disorder: Guidance for Healthcare Funders, Regulatory Bodies, Service Providers, and Consumers. 2024. Accessed April 9, 2026. https://www.casproviders.org/asd-guidelines
3. Djulbegovic B, Guyatt GH. Progress in evidence-based medicine: a quarter century on. Lancet. 2017;390(10092):415-423. doi:10.1016/S0140-6736(16)31592-6
4. Nejstgaard CH, Bero L, Hróbjartsson A, et al. Conflicts of interest in clinical guidelines, advisory committee reports, opinion pieces, and narrative reviews: associations with recommendations. Cochrane Database Syst Rev. 2020;12(12):MR000040. doi:10.1002/14651858.MR000040.pub3
5. Institute of Medicine. Clinical Practice Guidelines We Can Trust. The National Academies Press; 2011. Accessed April 9, 2026. https://nap.nationalacademies.org/catalog/13058/clinical-practice-guidelines-we-can-trust
6. Council of Autism Service Providers and Association of Professional Behavior Analysts. The Autism
   Spectrum Disorders (ASD) Assessment Guidelines for Behavior Analysts. 2026. Accessed March 13, 2026.
   https://www.casproviders.org/assessment-guidelines
7. Joseph A, Chong I, Das-Gupta Z, et al. Development of a standardized set of outcomes for autism spectrum disorder: the International Consortium for Health Outcomes Measurement (ICHOM). Res Autism Spectr Disord. 2024;117:102451. doi:10.1016/j.rasd.2024.102451
8. Georgiades S, Kasari C. Reframing optimal outcomes in autism. JAMA Pediatr. 2018;172(8):716-717. doi:10.1001/jamapediatrics.2018.1016
9. Bölte S, Mahdi S, de Vries PJ, et al. The gestalt of functioning in autism spectrum disorder: results of the international conference to develop final consensus International Classification of Functioning, Disability and Health core sets. Autism. 2019;23(2):449-467. doi:10.1177/1362361318755522
10. Kerns CM, Robins DL, Shattuck PT, Newschaffer CJ, Berkowitz SJ. Expert consensus regarding indicators of a traumatic reaction in autistic youth: a Delphi survey. J Child Psychol Psychiatry. 2023;64(1):50-58. doi:10.1111/jcpp.13666
11. Webster AC, Nagler EV, Gallagher M. Development of clinical practice guidelines in the care of people with kidney disease: core curriculum 2016. Am J Kidney Dis. 2016;67(3):516-531. doi:10.1053/j.ajkd.2015.08.030
12. Bennett K, Gorman DA, Duda S, Brouwers M, Szatmari P. Practitioner review: on the trustworthiness of clinical practice guidelines - a systematic review of the quality of methods used to develop guidelines in child and youth mental health. J Child Psychol Psychiatry. 2016;57(6):662-673. doi:10.1111/jcpp.12547
13. Ghadimi M, Guyatt G, Zaror C, et al. Trustworthiness of treatment clinical practice guidelines has modestly improved since the introduction of Institute of Medicine standards: a systematic survey. J Clin Epidemiol. 2025;187:111962. doi:10.1016/j.jclinepi.2025.111962